Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

316 studies match

clinicaltrialsPublishedShowing 201–250 of 316 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00983801	Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer	completed	Phase 2	58	R-PharmINDUSTRY	5	Oct 28, 2020	clinicaltrials
NCT02318368	A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label(FOCAL)	terminated	Phase 2	10	AVEO Pharmaceuticals, Inc.INDUSTRY	7	Oct 22, 2020